Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Aug 13:8:2111-20.
doi: 10.2147/OTT.S85130. eCollection 2015.

CAG repeat polymorphisms in the androgen receptor and breast cancer risk in women: a meta-analysis of 17 studies

Qixing Mao  1 , Mantang Qiu  1 , Gaochao Dong  2 , Wenjie Xia  1 , Shuai Zhang  3 , Youtao Xu  3 , Jie Wang  2 , Yin Rong  3 , Lin Xu  3 , Feng Jiang  3
Affiliations
Review

CAG repeat polymorphisms in the androgen receptor and breast cancer risk in women: a meta-analysis of 17 studies

Qixing Mao et al. Onco Targets Ther. .

Abstract

The association between polymorphic CAG repeats in the androgen receptor gene in women and breast cancer susceptibility has been studied extensively. However, the conclusions regarding this relationship remain conflicting. The purpose of this meta-analysis was to identify whether androgen receptor CAG repeat lengths were related to breast cancer susceptibility. The MEDLINE, PubMed, and EMBASE databases were searched through to December 2014 to identify eligible studies. Data and study quality were rigorously assessed by two investigators according to the Newcastle-Ottawa Quality Assessment Scale. The publication bias was assessed by the Begg's test. Seventeen eligible studies were included in this meta-analysis. The overall analysis suggested no association between CAG polymorphisms and breast cancer risk (odds ratio [OR] 1.031, 95% confidence interval [CI] 0.855-1.245). However, in the subgroup analysis, we observed that long CAG repeats significantly increased the risk of breast cancer in the Caucasian population (OR 1.447, 95% CI 1.089-1.992). Additionally, the risk was significantly increased in Caucasian women carrying two alleles with CAG repeats ≥22 units compared with those with two shorter alleles (OR 1.315, 95% CI 1.014-1.707). These findings suggest that long CAG repeats increase the risk of breast cancer in Caucasian women. However, larger scale case-control studies are needed to validate our results.

Keywords: CAG repeat polymorphism; androgen; breast cancer; meta-analysis; risk; women.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram.
Figure 2
Figure 2
Forest plot of SS versus all SL-LL and Forest plot of the subgroup analysis (SS versus all SL-LL). Notes: Weights are from random effects analysis; SS, women carrying two shorter alleles; SL, women carrying at least one long allele; LL, women carrying two long alleles. Abbreviations: OR, odds ratio; CI, confidence interval.
Figure 2
Figure 2
Forest plot of SS versus all SL-LL and Forest plot of the subgroup analysis (SS versus all SL-LL). Notes: Weights are from random effects analysis; SS, women carrying two shorter alleles; SL, women carrying at least one long allele; LL, women carrying two long alleles. Abbreviations: OR, odds ratio; CI, confidence interval.
Figure 3
Figure 3
Forest plot of the subgroup analysis (SS versus SL-LL). Notes: Weights are from random effects analysis; SS, women carrying two shorter alleles; SL, women carrying at least one long allele; LL, women carrying two long alleles. Abbreviations: OR, odds ratio; CI, confidence interval.
Figure 4
Figure 4
Forest plot of the subgroup analysis (SS versus LL). Notes: Weights are from random effects analysis; SS, women carrying two shorter alleles; SL, women carrying at least one long allele; LL, women carrying two long alleles.
Figure 5
Figure 5
Begg’s test for publication bias. Abbreviation: SE (logOR), standard error for log odds ratio.
See this image and copyright information in PMC

References

    1. Wiseman RA. Breast cancer hypothesis: a single cause for the majority of cases. J Epidemiol Community Health. 2000;54:851–858. - PMC - PubMed
    1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10–29. - PubMed
    1. Giguere Y, Dewailly E, Brisson J, et al. Short polyglutamine tracts in the androgen receptor are protective against breast cancer in the general population. Cancer Res. 2001;61:5869–5874. - PubMed
    1. Given HF, Radbourne R, Oag H, et al. The androgen receptor exon 1 trinucleotide repeat does not act as a modifier of the age of presentation in breast cancer. Eur J Cancer. 2000;36:533–534. - PubMed
    1. Dagan E, Friedman E, Paperna T, Carmi N, Gershoni-Baruch R. Androgen receptor CAG repeat length in Jewish Israeli women who are BRCA1/2 mutation carriers: association with breast/ovarian cancer phenotype. Eur J Hum Genet. 2002;10:724–728. - PubMed